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Background: The MetNI transporter drives methionine import against its concentration gradient and regulates intracel-
lular methionine levels.
Results:Methionine is a noncompetitive inhibitor of MetNI ATPase activity, binding the transporter at two allosteric sites.
Conclusion:MetNI regulates intracellular methionine concentrations via allosteric regulation.
Significance:Regulation ofmethionine import at the protein level mayminimize wasteful consumption of ATPwhen adequate
intracellular supplies are available.
The MetNI methionine importer of Escherichia coli, an ATP
binding cassette (ABC) transporter, uses the energy of ATP
binding and hydrolysis to catalyze the high affinity uptake of D-
and L-methionine. Early in vivo studies showed that the uptake
of external methionine is repressed by the level of the internal
methionine pool, a phenomenon termed transinhibition. Our
understanding of the MetNI mechanism has thus far been lim-
ited to a series of crystal structures in an inward-facing confor-
mation. To understand the molecular mechanism of transinhi-
bition, we studied the kinetics of ATP hydrolysis using
detergent-solubilized MetNI. We find that transinhibition is
due to noncompetitive inhibition by L-methionine, much like a
negative feedback loop. Thermodynamic analyses revealed two
allosteric methionine binding sites per transporter. This quan-
titative analysis of transinhibition, the first to our knowledge for
a structurally defined transporter, builds upon the previously
proposed structurally based model for regulation. This mecha-
nism of regulation at the transporter activity level could be
applicable to not onlyABC transporters but other types ofmem-
brane transporters as well.
Early in vivo studies by Kadner and colleagues (1, 2) estab-
lished that Escherichia coli utilizes a high affinity transport sys-
tem that mediates the energy-dependent uptake of D- and
L-methionine into cells. These elegant studies further demon-
strated that uptake of external methionine is repressed by the
level of the internal methionine pool, a phenomenon called
transinhibition (3). As a result, the cell is able to regulate uptake
of extracellular methionine to maintain an appropriate intra-
cellular concentration, thereby minimizing the wasteful con-
sumption of energy.
The high affinity import system of E. coli was subsequently
identified as MetNI, a member of the ATP binding cassette
(ABC)2 family of transporters (4–6). The MetNI importer, as
with all ABC transporters, consists of two nucleotide binding
domains (NBDs) and two transmembrane domains (TMDs)
(7). ATP binding and hydrolysis occur at the interface between
the highly conservedNBDs, where ATP is sandwiched between
the Walker A motif of one monomer and the ABC motif
(LSGGQ) on the other (8–10). Based on the TMD fold
observed in the crystal structure (see Fig. 1A), MetNI was cat-
egorized as a Type I importer, with other structurally charac-
terized members including the ModBC molybdate transporter
and theMalFGK2maltose transporter (11–14). For this class of
importers, the alternating access transport mechanism pro-
poses that ATP binding at the NBD interface induces the clo-
sure, or “dimerization” of the two domains, thereby promoting
an outward-facing conformation of the TMDs (15). The inter-
nal cavity of the transporter is thus open to receive substrate
from the cognate periplasmic binding protein. SubsequentATP
hydrolysis releases NBD dimerization and converts the TMDs
to an inward-facing conformation where substrate can be
released to the cytoplasm (see Fig. 1B).
In addition to this common domain architecture, the MetNI
NBDs are fused to two carboxyl-terminal domains, termed C2,
which are believed to be crucial for transinhibition (11, 12). The
MetNI C2 domains are distinct from those found on the
ModBC andMalFGK2 transporters, although all are implicated
in regulatory roles of transport (13, 16). The high-resolution
crystal structure of MetNI shows the NBDs widely separated
due to dimerization of their C2 domains (see Fig. 1A). Sel-
enomethionine has been shown to bind the C2 domains and
inhibit ATPase activity. Based on these findings, it has been
proposed that ligand-dependent association of the C2 domains
prevents dimerization of theNBDs. Because the twoATP bind-* Thisworkwas supported, inwholeor inpart, byNational Institutes ofHealth
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ing pockets are created at this dimerization interface, physical
separation of the NBDs will prevent ATP binding and hydroly-
sis, thereby inhibiting transport (see Fig. 1B) (11).
MetNI provides a rare opportunity to develop detailed
kinetic and thermodynamic analyses to study themechanismof
a structurally characterized ABC transporter. As a starting
point, we examine the kinetics of ATP hydrolysis to elucidate
the mechanism of MetNI transinhibition. To focus on the
inhibitory effects of methionine, we employed a basic experi-
mental system consisting of detergent-solubilizedMetNI in the
absence ofMetQ, the substrate-containing cognate periplasmic
binding protein. Although MetQ will clearly influence the
structure and activity of MetNI (see Ref. 17 for an informative
discussion of the maltose transport system), it will also compli-
cate an analysis of the role of methionine because the stimulat-
ing effect of MetQ on the ATPase activity is opposite of the
allosteric effect of methionine. As a consequence, we have not
includedMetQ in these studies. Additionally, the basal ATPase
activity of detergent-solubilized ABC transporters typically
increases and the coupling efficiency decreases, relative to the
behavior in a phospholipid bilayer, as again exemplified by the
maltose transporter (see Ref. 18). Although ATPase activity
uncoupled to transport is not the physiological reaction of ABC
transporters, comparisons of ABC subunits in isolation and in
transporters are suggestive of a common mechanism for ATP
hydrolysis (19). Consequently, meaningful kinetic interpreta-
tions can be derived from the effects of methionine on the rel-
ative ATPase activity of MetNI in our simplified system. We
find that transinhibition is due to noncompetitive inhibition by
L-methionine and that there are two allosteric methionine
binding sites per transporter. These findings are consistent
with the structurally basedmodel for transinhibition and could
be extended to understanding the regulation of the broader
ABC family.
EXPERIMENTAL PROCEDURES
Protein Expression and Purification—The wild-type His-
tagged MetNI expression plasmid (11) was transformed into
BL21-Gold (DE3) cells (Novagen). Cell growthwas carried out
at 37 °C in Terrific Broth containing 1% glucose and 100 g/ml
ampicillin. Protein expression was induced by the addition of
isopropyl -D-1-thiogalactopyranoside to 1 mM for 1 h. Cells
were harvested by centrifugation and stored at80 °C.
Frozen cell pellets were homogenized in purification buffer
(50 mM TAPS, pH 8.5, 250 mM NaCl, 0.05% n-dodecyl-
-D-maltopyranoside (DDM, Anatrace)) supplemented with
DNase, lysozyme, and protease inhibitor tablets (Roche Diag-
nostics GmbH). To extract MetNI protein, DDMwas added to
1.0% final concentration. Cells were stirred at 4 °C for 20 min
and then passed through a Microfluidizer three times. The cell
lysate was stirred for 20min and then spun for 20min at 16,000
rpm in a JLA 17 rotor. The supernatant was recovered, and
imidazole was added to 25 mM final concentration. The super-
natant was then flowed over three tandem 5-ml HisTrap FF
columns (GE Healthcare) and washed with 2 column volumes
of purification buffer containing 25 mM imidazole and 5 col-
umn volumes of purification buffer containing 75 mM imidaz-
ole. MetNI protein was eluted with purification buffer contain-
ing 350 mM imidazole. Eluate was then buffer-exchanged into
purification buffer without imidazole using a HiPrep 26/10
desalting column (GE Healthcare). The protein was then sized
over a Superdex 200 column (GEHealthcare) and concentrated
to60 M in an Amicon Ultra 100-kDa molecular mass cutoff
centrifugal filter (Millipore) prewashed in purification buffer.
Purified protein was flash-frozen in LN2 and stored at80 °C.
ATPase Assays—The amount of inorganic phosphate gener-
ated in solution was measured in real time using the Enzchek
phosphate assay kit (Molecular Probes). Each 100-l reaction
contained 60 mM Tris, pH 7.5, 5 mM TAPS, pH 8.5, 0.055%
DDM, 55mMNaCl, 200M 2-amino-6-mercapto-7-methylpu-
rine riboside, 0.1 units of purine nucleoside phosphorylase,
equimolar amounts of MgCl2 and ATP and/or ADP, and L-me-
thionine as indicated. Data were collected on an Infinite M200
microplate reader (TecanGroup) at 33 °C. Reactionswere incu-
bated for 2 min and then initiated by automatic injection of
MetNI (supplemental Fig. S1). For measurement of KI(ADP), 3
M MetNI final concentration was injected into reactions con-
taining 100 MMgATP. For all other measurements, reactions
contained 410 nM MetNI. Initial rates were obtained by calcu-
lating the linear portion of the change in absorbance at 360 nm
as a function of time using Magellan software. Error bars rep-
resent S.E. from at least three independent experiments.
All data were fit using KaleidaGraph (Synergy Software). For
determination of KI values, the initial rate was plotted against
inhibitor concentration and fit to the following equation
v 
Vmax
app
1
InI
KI
nI
(Eq. 1)
where [I] is the inhibitor concentration, KI is the inhibition
constant, and nI is the Hill coefficient for the inhibitor.
For determination of Km(ATP), Vmax, and the Hill coefficient
nATP, the initial ratewas plotted againstATPconcentration and
fit to the following equation
v 
Vmax ATP
nATP
Km
nATP ATPnATP
(Eq. 2)
Isothermal Titration Calorimetry—MetNI was further con-
centrated to 350–450 M in an Amicon Ultra 100-kDa molec-
ularmass cutoff centrifugal filter (Millipore) prewashed in puri-
fication buffer. Samples were then dialyzed overnight in
purification buffer in 100-kDa molecular mass cutoff Slide-a-
Lyzer MINI dialysis devices (Thermo Scientific). The next day,
samples were recovered and cleared at 95,000 rpm for 10min in
a TLA100 rotor. L-Methionine (BioUltra, Sigma) was reconsti-
tuted in the purification buffer used for dialysis. Binding data
were collected on a MicroCal iTC-200 calorimeter at 25 °C.
300–450 M MetNI was titrated with 8–10 mM L-methionine.
For each experiment, an initial injection of 0.4 l was followed
by 19 injections of 2 l each. The sample cell was allowed to
equilibrate for 180 s between titrations. Data were processed
using Origin v7.0 (OriginLab). Error bars represent S.E. from at
least three independent experiments.
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RESULTS
To establish the kinetic mechanism of transinhibition, we
measured the ATPase activity of detergent-solubilized, wild-type
MetNIusingacontinuousspectrophotometriccoupledenzymatic
assay (see “Experimental Procedures”). Todefine the basic param-
eters of the assay,MetNIwas automatically injected into reactions
containing varying concentrations of MgATP. The initial rates
were plotted and fit to a sigmoidal curve with Km 330 20M
and aHill coefficient of 1.7 0.1, indicating positive cooperativity
between the twoATPbinding pockets (Fig. 1C and supplemental
Fig. S1). Cooperative binding of ATP is a common feature of sev-
eral ABC transporters, including the vitamin B12, maltose, and
histidine transporters (20–23).
We then verified the competitive nature of nucleotide inhi-
bition of MetNI ATPase activity. Because canonical nucleotide
analogs for ATP, including AMPPNP, AMPPCP, and ATPS,
did not completely inhibit ATPase activity in the concentration
range tested (data not shown), we measured ATPase inhibition
using ADP. Under subsaturating ATP concentrations, ADP
inhibited MetNI ATPase activity with a KI(ADP) of 41  2 M
and a Hill coefficient of 1.3 0.1, indicating low cooperativity
for the binding of ADP (Fig. 2A and Table 1). Next, the ATP
concentration was varied under constant ADP concentrations
both above and below the measured KI(ADP). In the presence of
ADP, the apparent Vmax remained unchanged, whereas the
apparent Km increased with increasing inhibitor concentration
(Fig. 2B and Table 2). As expected, these experiments con-
firmed that ADP is indeed a competitive inhibitor.
We next tested L-methionine inhibition of MetNI ATPase
activity. Inhibition experiments under saturatingATPconcentra-
tions were fit to a KI(L-Met) of 41 1 M and a Hill coefficient of
1.4 0.1, indicating that there ismore than onemethionine bind-
ing site perMetNI transporter and low cooperativity between the
sites (Fig. 3A and Table 1). Furthermore, with increasing L-methi-
onine concentrations, the apparent Vmax significantly decreased,
whereas the apparentKm remained constant (Fig. 3B andTable 2).
These data suggest that L-methionine is a noncompetitive inhibi-
tor of MetNI ATPase activity. To further support this model, we
conducted isothermal titration calorimetry experiments using
L-methionine as the ligand (Fig. 3C). L-Methionine bound to
MetNI at 2.2 0.1 sites, with a KD(L-Met) of 33 4 M. Although
theerror estimatesprovidedby the software analysis are artificially
low (see reduced 	-squared values for fixed values of stoichiome-
try, Fig. 3C, inset), the measured value for the KD(L-Met) is in the
same order of magnitude of the KI(L-Met) for the ATPase reaction
(41 1M).
DISCUSSION
Wehave demonstrated that L-methionine can bind toMetNI
at allosteric sites, resulting in the noncompetitive inhibition of
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FIGURE 1. Binding of ATP to MetNI is cooperative. A, representation of MetNI structure and domains within the cell membrane (11). B, alternating access
model for transport with the addition of the transinhibitionmodel. C, ATPase activity ofMetNI in the absence of inhibitors. Inset, observed rate constant at low
concentrations of MgATP. Reaction conditions consisted of 60 mM Tris, pH 7.5, 5 mM TAPS, pH 8.5, 0.055% DDM, 55 mM NaCl, 200 M 2-amino-6-mercapto-7-
methylpurine riboside, 0.1 units of purine nucleoside phosphorylase per 100 l, and equimolar amounts of MgCl2 and ATP at 33 °C. Equations for fitting are
described under “Experimental Procedures.” Error bars represent S.E. from at least three independent experiments.
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ATP hydrolysis. This direct modulation of MetNI activity is
consistent with the model based on the crystallographically
observed ATPase-inactive state of MetNI. Our data suggest
that the transinhibition phenomenon observed by Kadner (3)
can be attributed to the regulation of methionine import at the
protein activity level. The de novo biosynthesis ofmethionine in
E. coli is costly, requiring 7 ATPs and 8 NADPHs per molecule
of methionine (24). If extracellular methionine is available,
uptake of the exogenous methionine at an estimated cost of
2 ATPs per methionine molecule would be energetically
preferable to de novo biosynthesis. The homeostatic intra-
cellular concentration of methionine is estimated to be 150
M (25), maintained by the balance between the rate of
appearance of methionine via the MetNI import system
and/or the methionine biosynthesis pathway and the rate of
disappearance via protein synthesis and other processes.
Given the KI for methionine inhibition measured in this
study (40M), uptake should occur under conditions when
the intracellular levels of methionine are well below 150 M,
with the rate of transport decreasing as the interior concen-
tration increases.
Several aspects of our study are worth detailing. We have
kinetically analyzed the influence ofmethionine on the ATPase
activity of detergent-solubilized MetNI in the absence of the
MetQ binding protein and in the absence of phospholipid. For
the kinetic analysis, we have used the simplest models for non-
competitive and competitive inhibition to treat the effects of
methionine and ADP, respectively, on ATPase activity. These
models do not include binding interactions between ligands.
We have explored more complex kinetic models (see the
supplemental text), which suggest that little interaction occurs
in the binding of these ligands. Given the correlation of param-
eters intrinsic to these binding models (26), it is not possible to
confidently assess the magnitudes of these effects. The MetQ
binding protein was not utilized in these studies to avoid the
opposing effects ofmethionine onATPase activity due to trans-
port (requiring methionine-bound MetQ) and to transinhibi-
tion (requiring methionine acting as an allosteric ligand). We
have focused on detergent-solubilized MetNI to directly char-
acterize the influence of methionine on the ATPase activity of
the form ofMetNI that has been crystallographically character-
ized. Although the physiological function of ABC transporters
requires membranes, detergent-solubilized transporters can
capture important functional properties. The most extensive
mechanistic studies of ABC importers have been conducted for
the MalFGK2 transporter; although the detailed properties dif-
fer, the cooperativity of ATP hydrolysis can be observed for
both detergent-solubilized and proteoliposome-reconstituted
ABC transporters (22). Furthermore, complexes between the
maltose transporter and binding protein can be trapped using
ATP 	 vanadate with either membrane-bound or detergent-
solubilized transporter (27). Unquestionably, the structural
studies on detergent-solubilized maltose transporter from the
Chen group (14, 17) and on detergent-solubilized vitamin B12
transporter from the Locher group (20, 28) have provided an
invaluable framework for the interpretation of mechanistic
studies of transport in proteoliposomes.
ABC transporters have adopted a wide range of mechanisms
to regulate their activity. The molybdate/tungstate transporter
ModBC shares a similar architecturewithMetNI and also dem-
onstrates transinhibitory behavior at higher concentrations of
substrate (13). Themaltose transporter, in contrast, is regulated
by an additional protein that responds to nutrient availability.
Unphosphorylated EIIAGlc binds MalFGK2 when preferred
sources of carbon, such as glucose, are available (29). Two
EIIAGlc molecules bind the NBDs and promote the inward-
facing conformation reminiscent of the MetNI inhibited
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FIGURE 2.ADP is a competitive inhibitor ofMetNI ATPase activity.A, inhibition ofMetNI ATPase activity as a function of ADP concentration. Inset, observed
rate constant at low concentrations of MgATP. B, ATPase activity as a function of ATP concentration in the presence of different concentrations of ADP.
Reaction conditions were identical with those in Fig. 1. Error bars represent S.E. from at least three independent experiments.
TABLE 1
Inhibition constants
Inhibitor KI Hill coefficient
M
ADP 41 2 1.3 0.1
L-Met 41 1 1.4 0.1
TABLE 2
Kinetic parameters from the ATPase reaction
Inhibitor Vmaxapp Kmapp
min1 M
None 17 1 330 20
30 M ADP 19 1 660 40
75 M ADP 21 1 1170 80
120 M ADP 20 1 1490 140
25 M L-Met 13 1 309 19
50 M L-Met 7 1 325 15
Regulation ofMethionine Import viaMetNI Transinhibition
9138 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 290•NUMBER 14•APRIL 3, 2015
 at U
N
IV
 O
F SA
N
 FRA
N
CISCO
 on A
pril 25, 2017
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
state (16). Interestingly, it has been demonstrated that the
binding of EIIAGlc does not affect the binding of ATP but
rather inhibits ATP hydrolysis by MalK (30). Quantitative
modeling of our MetNI data suggests that methionine may
similarly inhibit ATP hydrolysis but not ATP binding (see
the supplemental text).
Although the above examples highlight inhibition as the
result of a stabilized inward-facing conformation, ABC trans-
porters are also regulated at the level of transcription, glycosyl-
ation, and direct phosphorylation. For example, the osmoregu-
latory transporterOpuA is regulated by the transcription factor
OpuR in response to osmotic stress (31). CFTR (cystic fibrosis
transmembrane conductance regulator), an ABC-type chloride
channel whose malfunction is linked to cystic fibrosis, is gated
by PKA-mediated phosphorylation of its cytoplasmic regula-
tory domain (32–35). Lastly, it is hypothesized that glycosylation
mayhelp stabilize the rodphotoreceptorABCtransporter (ABCR)
against degradation while in the endoplasmic reticulum (36).
TheregulationofABCtransporters,whether throughaccessory
proteins, regulatory domains, or posttranslational modifications,
is critical to balance the transport of metabolites for optimal
growth. TheMetNI transporter, through transinhibition, is effec-
tively able to shut off import when adequate intracellular methio-
nine is available for crucial cellular processes. A possible mecha-
nism for this phenomenon envisioned nearly 40 years ago by
Kadner (3) on the basis of transport studies in E. coli cells (“ . . .
internalmethionine binds to the carrier on the internal face of the
membrane. Thismethionine-carrier complexmight be unable, or
at least less able, to undergo the energy-dependent change neces-
sary for active transport . . . ”) was prescient, as the present studies
have established using purified components. Significantly, the
underlying mechanism (ligand binding to regulatory domains
inhibits NBD dimerization, thereby preventing ATP hydrolysis
and effectively “turning off the engine”) exemplifies a broadly rel-
evantmechanismfor regulating theactivityofABCtransporters at
the protein level.
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FIGURE 3. L-Methionine is a noncompetitive inhibitor. A, inhibition of MetNI ATPase activity as a function of L-Met concentration. Inset, observed rate
constant at low concentrations of MgATP. B, ATPase activity as a function of ATP concentration in the presence of different concentrations of L-Met.
Reaction conditions for ATPase assays were identical with those in Fig. 1. Error bars represent S.E. from at least three independent experiments. C, top,
representative ITC thermogram profile for association of L-Met ligand with MetNI reactant. Bottom, binding curve from plot of heats from each injection
as a function of the ratio of L-Met to MetNI, c  14. Buffer conditions for ITC experiments consisted of 50 mM TAPS, pH 8.5, 250 mM NaCl, 0.05%
n-dodecyl--D-maltopyranoside at 25 °C. Binding of L-methionine was exothermic with 
H2140 40 cal mol1. Inset: reduced 	-squared value for
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